KYTX
KYTX

Kyverna Therapeutics Inc

NASDAQ · Biotechnology
$7.93
+0.66 (+9.08%)
Analyst Consensus
Strong Buy
12 analysts
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +2.9% upside
Low Target $5.68
Average Target $8.16
High Target $10.96
Current Price $7.93
Current
$7.93
Target
$8.16
$5.68 $8.16 avg $10.96